Discovery biology

Discovery biology

Eviogen’s biologists are well-positioned to meet the diverse drug discovery needs of our global life sciences customers. Eviogen offers clients a diversity of integrated drug discovery and screening services ranging from target identification, validation, expression, structural characterization, establishment of in-vitro and in-vivo models suited for the testing of therapeutic molecules, as well as the evaluation of their safety and pharmacokinetics profiles when administered.
We work closely with start-ups, pharmaceuticals and research institutes in an integrated way to support their discovery biology needs, including ADMET, pharmacology and toxicology studies, in-vitro and in-vivo studies, molecular cloning and expression/ purification of proteins as needed.